{"id":193500,"name":"ABBVIE INC.","slug":"abbvie-inc","state":"DC","description":"Biopharmaceutical company.","totalSpending":1250000,"filings":25,"yearlySpending":[{"year":2018,"income":200000},{"year":2019,"income":200000},{"year":2020,"income":150000},{"year":2021,"income":200000},{"year":2022,"income":200000},{"year":2024,"income":150000},{"year":2025,"income":150000}],"firms":["W STRATEGIES, LLC"],"lobbyists":["DARREN WILLCOX"],"issues":["BUD","HCR","MMM","PHA"],"sampleDescriptions":["H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal.\n\nH.R.1625: Consolidated Appropriations Act, 2018.","Education about the 340(b) drug discount program.\n\nH.R.4710: 340(b) PAUSE Act.\n\nEducation about Endometriosis Awareness Month and the need for greater awareness of the disease.","Education about the 340(b) drug discount program.\n\nH.R.4710: 340(b) PAUSE Act.\n\nH.R.5598: 340B Optimization Act.\n\nEducation about Endometriosis Awareness Month and the need for greater awareness of the disease.","Education about the 340(b) drug discount program.\n\nH.R.4710: 340(b) PAUSE Act.\n\nH.R.5598: 340B Optimization Act.","H.R.6642: \"to sunset the limit on the maximum rebate amount for single source drugs\".","H.R.7217: IMPROVE Act.","H.R.259: Medicaid Extenders Act of 2019.\n\nEducation about out of pocket costs for patients in Medicare Part D.\n\nEducation about CMS rule changing protections for beneficiaries in Medicare Part D six protected classes.  \n\nRegulatory and legislative proposals in the Administrations Blueprint.","Education about the 340(b) drug discount program.","Education about the 340(b) drug discount program.\n\nH.R.2113: Prescription Drug STAR Act.\n\nS. Lower Health Care Costs Act of 2019.","Education about out of pocket costs for patients in Medicare Part D.\n\nRegulatory and legislative proposals in the Administrations Blueprint.","Education about out of pocket costs for patients in Medicare Part D.\n\nS.2543: Prescription Drug Pricing Reduction Act of 2019.\n\nRegulatory and legislative proposals in the Administrations Rx Blueprint.\n\nH.R.3: Lower Drug Costs Now Act of 2019.","Education about out of pocket costs for patients in Medicare Part D.\n\nH.R.3: Lower Drug Costs Now Act of 2019.\n\nH.R.19: Lower Costs, More Cures Act of 2019.","Legislative proposals to smooth out of pocket costs for patients in Medicare Part D.\n\nFY 2021 Notice of Benefits and Payment Parameters proposed rule.","Education about the 340(b) drug discount program.\nH.R.1425: Patient Protection and Affordable Care Enhancement Act.","FY 2021 Notice of Benefits and Payment Parameters proposed rule.\n\nCMS proposed rule on Medicaid Drug Rebate program.","H.R.7647: To provide for a COVID-19-related delay regarding annual limitation on cost-sharing for group health plans and individual and small group health insurance coverage.\n\nFY 2021 Notice of Benefits and Payment Parameters proposed rule.\n\nCMS proposed rule on Medicaid Drug Rebate program.","Education about the 340(b) drug discount program.  \n\nFY 2021 NBPP rule as it relates to copay accumulators.","Issues related to pharmaceutical intellectual property.","Monitored issues and legislation related to 340(b) program.","Monitored issues and legislation related to 340(b) program.\n\nH.R.5801: HELP Copays Act."],"years":[2018,2019,2020,2021,2022,2024,2025]}